Venture Capital
New York
ExSight Ventures (EV) is a returns-oriented, mission-focused life sciences venture capital firm specializing in early-stage investments in innovative ophthalmic diagnostic and treatment solutions. We created the firm to address the dearth of early-stage funding available to life science companies. Our team consists of two accomplished retinal surgeons and utilizes their deep domain expertise and networks to drive our insights and ability to invest early. We rely on our team’s diverse experiences in venture capital and healthcare in our investment selection process and subsequently, to assist our portfolio companies. EV invests in biotechnology, medical devices, pharmaceuticals, and software solutions with ophthalmic applications.
051424sbs
